ChromaDex Stock Quote CDXC - Stock Price, News, Charts, Message Board, Trades

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

2.58

Bid

2.54

Ask

2.88

Volume

234,013

2.55 Day's Range 2.71

1.25 52 Week Range 4.65

Market Cap

194.135M

Previous Close

2.69

Open

2.68

Last Trade

2.58

Last Trade Time

Financial Volume

$ 612,562

VWAP

2.6176

Average Volume (3m)

389,267

Shares Outstanding

75,538,787

Dividend Yield

PE Ratio

-39.30

Earnings Per Share (EPS)

-0.07

Revenue

83.57M

Net Profit

-4.94M

ChromaDex Corp is a bioscience company dedicated to healthy aging. The ChromaDex team is engaged in research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. The company is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship in... ChromaDex Corp is a bioscience company dedicated to healthy aging. The ChromaDex team is engaged in research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. The company is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen. Nicotinamide riboside and other NAD+ precursors are protected by ChromaDex's patent portfolio. It delivers Niagen as the sole active ingredient in its consumer product namely, Tru Niagen which is available on Tru Niagen's website and through partnerships with retailers and distributors. Show more

Sector

Medicinal Chems,botanicl Pds

Industry

Medicinal Chems,botanicl Pds

Website

www.chromadex.com

Headquarters

Dover, Delaware, USA

Founded

1970

ChromaDex Corporation is listed in the Medicinal Chems,botanicl Pds sector of the NASDAQ with ticker CDXC. The last closing price for ChromaDex was $2.69. Over the last year, ChromaDex shares have traded in a share price range of $ 1.25 to $ 4.65.

ChromaDex currently has 75,538,787 shares outstanding. The market capitalization of ChromaDex is $194.13 million. ChromaDex has a price to earnings ratio (PE ratio) of -39.30.

ChromaDex to Join Russell 2000® Index

ChromaDex continues to drive innovation and growth with its proprietary Tru Niagen® supplement, backed by strong financial performance and a robust intellectual property portfolio ChromaDex Corp...

Milestone Phase II Clinical Study Demonstrates Niagen®, Patented Nicotinamide Riboside (NR), Improves Functional Mobility for Individuals with Peripheral Artery Disease (PAD)

NR improved the six-minute walking distance and treadmill walking time for those with PAD ChromaDex Corp. (NASDAQ:CDXC), the global authority on nicotinamide adenine dinucleotide (NAD+) research...

ChromaDex to Launch Niagen+, the First-Of-Its-Kind Pharmaceutical-Grade Intravenous and Injectable Niagen® (Patented Nicotinamide Riboside Chloride or NRC)

Clinical study results demonstrated that Niagen IV had no adverse side effects, provided superior tolerability, and a 75% shorter infusion time, with blood NAD+ levels peaking sooner and higher...

ChromaDex Receives Exclusive U.S. FDA Orphan Drug Designation (ODD) and Rare Pediatric (RPD) Disease Designation for Nicotinamide Riboside Chloride (NRC) for the Treatment of Ataxia Telangiectasia (AT)

ChromaDex plans to conduct additional studies on NRC in anticipation of filing for an Investigational New Drug Application (IND) for the treatment of AT ChromaDex Corp. (NASDAQ:CDXC), the global...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.08	3.2	2.5	2.85	2.305	1599558	2.70486196	CS
4	-0.36	-12.2448979592	2.94	3.49	2.305	671552	2.80401324	CS
12	-1.71	-39.8601398601	4.29	4.3099	2.305	389267	3.0853161	CS
26	1.16	81.6901408451	1.42	4.65	1.36	312534	3.00417499	CS
52	1.03	66.4516129032	1.55	4.65	1.25	198276	2.68013779	CS
156	-7.3	-73.8866396761	9.88	10.54	1.15	285036	3.22219495	CS
260	-1.81	-41.2300683371	4.39	23.66	1.15	492369	8.26400178	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
RDZNRoadzen Inc	$ 2.95 (82.10%)	108.01M
SYTSYLA Technologies Company Ltd	$ 3.05 (59.69%)	6.19M
VSVersus Systems Inc	$ 1.90 (43.94%)	58.92M
VIVKVivakor Inc	$ 3.41 (36.95%)	727.57k
MEDSTRxADE HEALTH Inc	$ 18.585 (30.70%)	397.66k
MAXNMaxeon Solar Technologies Ltd	$ 0.18 (-67.20%)	173.94M
RNACCartesian Therapeutics Inc	$ 15.7715 (-35.02%)	1.45M
EFTReFFECTOR Therapeutics Inc	$ 0.18 (-32.56%)	1.63M
DTSSDatasea Inc	$ 3.43 (-30.57%)	1.15M
ARDXArdelyx Inc	$ 5.29 (-30.12%)	22.67M
NVDANVIDIA Corporation	$ 122.67 (-1.31%)	220.38M
TSLATesla Inc	$ 231.26 (10.20%)	205.05M
MAXNMaxeon Solar Technologies Ltd	$ 0.18 (-67.20%)	173.94M
SQQQProShares UltraPro Short QQQ	$ 7.88 (-2.96%)	114.59M
RDZNRoadzen Inc	$ 2.95 (82.10%)	108.01M